The task at hand now is to get the remaining warrants cashed. The .10 will be easy, but the .38 warrants are a little different and still have 21 months to expirey.
The next thing we need to hear is that we are setting up shop in UC Davis for the next round of testing.
I am not sure if they can report on FDA progress or lack of, until it's completed.
The risk/reward in this stock is tremendous. These prices are still cheap as hell.
This company has put all long term shareholders through the ringer with their timelines. But they did just knock one out. Unfortunately I think they knocked it out last month and delayed telling us because of a social media mistake.
Nonetheless on to the next phase. Good luck.
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM